Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "artificial"

312 News Found

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems


Gen Z split on AI as global study reveals rising tech optimism
Technology | April 30, 2026

Gen Z split on AI as global study reveals rising tech optimism

Health innovations are viewed more positively than food and agricultural technologies


Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics
interviews | April 29, 2026

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies


Illuminova ’26 showcases AI-driven future of medical education at SRM
Healthcare | April 29, 2026

Illuminova ’26 showcases AI-driven future of medical education at SRM

SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence


IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach
Healthcare | April 27, 2026

IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach

The deal signals a clear push to expand access to care in underserved regions


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future
Digitisation | April 24, 2026

Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future

The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations


AbbVie bets $1.4B on North Carolina pharma mega-campus
News | April 23, 2026

AbbVie bets $1.4B on North Carolina pharma mega-campus

Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing


India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation
News | April 23, 2026

India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation

New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements


New brain study reveals why alcohol relapse remains a persistent challenge
R&D | April 22, 2026

New brain study reveals why alcohol relapse remains a persistent challenge

These findings help explain how relapse-triggering memories can persist alongside those that support recovery